November 17, 2010

Rheonix Announces Issuance of New Patent for its Microfluidic Diagnostic Platform

Ithaca, NY — November 17, 2010 — Rheonix, Inc., developer of the Rheonix CARD™ (Chemistry And Reagent Device) system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method” to the Company. The patent is the first granted for the Company’s core device, which… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More